DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

97.69 1.84 (1.92%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMRN $97.69 1.92%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $96.03
Previous Close $95.85
Daily Range $95.85 - $99.03
52-Week Range $55.04 - $100.50
Market Cap $14.4B
P/E Ratio -108.92
Dividend (Yield) $0.00 (0.0%)
Volume 1,687,975
Average Daily Volume 1,351,510
Current FY EPS -$1.06





BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website:

News & Commentary

Forget Marijuana Stocks: Here Are 3 Smarter Investments

Three Motley Fool contributors offer up investing ideas that may be smarter than investing in marijuana.

'Mad Money' Lightning Round: Constellation Brands the New King in Town

BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog

Health Care Sector Update for 01/22/2015: SHPG, NNVC, BMRN

Today's Post-Market Laggard Is Biomarin Pharmaceutical (BMRN)

State of the Union Address Investing Idea: Precision Medicine

There are plenty of companies developing precision medicine drugs already, and investors would be wise to watch key players.

State Of The Union Lights Up Biotech

8 Biotech Stock Controversies Emerging From 'JPM15' Conference

3 Warning Signs You've Invested in a Dangerous Biotech Stock

Three Motley Fool analysts help investors spot biotech stock warning signals.

Nomura Analyst Sees Fast Growth At BioMarin Pharmaceutical

See More BMRN News...

BMRN's Top Competitors

BMRN $97.69 (1.92%)
Current stock: BMRN
AMGN $159.81 (0.15%)
Current stock: AMGN
GILD $105.54 (0.38%)
Current stock: GILD
BIIB $357.63 (1.13%)
Current stock: BIIB